- Home
- BAH vs ICLR Comparison
BAH vs ICLR Comparison
Compare BAH & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BAH
- ICLR
- Stock Information
- Founded
- BAH 1914
- ICLR 1990
- Country
- BAH United States
- ICLR Ireland
- Employees
- BAH N/A
- ICLR 41250
- Industry
- BAH Professional Services
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- BAH Consumer Discretionary
- ICLR Health Care
- Exchange
- BAH Nasdaq
- ICLR Nasdaq
- Market Cap
- BAH 13.9B
- ICLR 11.4B
- IPO Year
- BAH 2010
- ICLR 1998
- Fundamental
- Price
- BAH $123.90
- ICLR $133.96
- Analyst Decision
- BAH Buy
- ICLR Buy
- Analyst Count
- BAH 12
- ICLR 12
- Target Price
- BAH $147.36
- ICLR $206.64
- AVG Volume (30 Days)
- BAH 1.7M
- ICLR 2.1M
- Earning Date
- BAH 05-23-2025
- ICLR 04-30-2025
- Dividend Yield
- BAH 1.77%
- ICLR N/A
- EPS Growth
- BAH 116.72
- ICLR 11.53
- EPS
- BAH 6.70
- ICLR 9.19
- Revenue
- BAH $11,776,700,000.00
- ICLR $8,192,621,999.00
- Revenue This Year
- BAH $13.99
- ICLR $1.63
- Revenue Next Year
- BAH $6.88
- ICLR $4.82
- P/E Ratio
- BAH $18.57
- ICLR $15.07
- Revenue Growth
- BAH 14.07
- ICLR N/A
- 52 Week Low
- BAH $101.05
- ICLR $133.28
- 52 Week High
- BAH $190.59
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- BAH 69.45
- ICLR 33.96
- Support Level
- BAH $118.35
- ICLR $135.00
- Resistance Level
- BAH $124.94
- ICLR $141.96
- Average True Range (ATR)
- BAH 2.96
- ICLR 6.69
- MACD
- BAH 0.64
- ICLR 0.43
- Stochastic Oscillator
- BAH 91.80
- ICLR 3.63
About BAH Booz Allen Hamilton Holding Corporation
Booz Allen Hamilton Holding Corp is a provider of management consulting services to the U.S. government. Other services offered include technology, such as cloud computing and cybersecurity consulting, and engineering consulting. The consulting services are focused on defense, intelligence, and civil markets. In addition to the U.S. government, Booz Allen Hamilton provides its management and technology consulting services to large corporations, institutions, and nonprofit organizations. The company assists clients in long-term engagements around the globe.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.